Yuan Chen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Combination of Almonertinib and Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC (NCT04952168) | Yuan Chen | 2021-06-02 |
Track Yuan Chen automatically
Every clearance here is in the API, with alerts when new ones post.